Jianjian Gong

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text

Medicine, Cardiology, Pharmacology +11

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Inder S. Anand et al. · New England Journal of Medicine · 2019 · 2.4K citations · Full text

Medicine, Cardiology, Pharmacology +15

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Scott D. Solomon, Michael R. Zile, Burkert Pieske et al. · The Lancet · 2012 · 1.2K citations

Medicine, Cardiology, Pharmacology +13

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Milton Packer, John J.V. McMurray, Akshay S. Desai et al. · Circulation · 2014 · 667 citations · Full text

Medicine, Cardiology, Pharmacology +16

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

Luís M. Ruilope, Andrej Dukát, Michael Böhm et al. · The Lancet · 2010 · 592 citations

Medicine, Pharmacology, Pharmacotherapy +17